Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.5.1.52 (
PNGase F
)
1,527
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
E-selectin
is a cytokine-inducible membrane glycoprotein capable of mediating adhesion of leukocytes to endothelial cells. It is highly glycosylated, containing 11 sites for N-linked glycosylation. N-Glycosylation of
E-selectin
was analyzed by endoglycosidase treatment. Analysis of immunoprecipitated
E-selectin
from human umbilical vein endothelial cells (HUVEC) by polyacrylamide gel electrophoresis in the presence of sodium dodecylsulfate showed that
E-selectin
was completely resistant to endoglycosidase H, but sensitive to peptide
N-glycanase
F digestion. This suggested that all N-linked oligosaccharide chains were of the complex type. The role of N-linked glycosylation in surface expression and secretion of
E-selectin
was studied using interleukin-1-stimulated HUVEC, cultured in the presence of the soluble glycosylation inhibitors tunicamycin or castanospermine. Cell surface expression was analyzed by indirect flow cytometry. N-Glycosylation was blocked by tunicamycin, and resulted in a significantly reduced surface expression of
E-selectin
, whereas castanospermine only marginally reduced
E-selectin
expression. The deglycosylated forms of
E-selectin
were also found to be fully capable of mediating adhesion of HT-29 cells in vitro. In conclusion, these studies show that
E-selectin
is heavily glycosylated with complex type N-linked oligosaccharides and that N-glycosylation is important for expression of
E-selectin
on human endothelial cells.
...
PMID:Role of N-linked glycosylation in expression of E-selectin on human endothelial cells. 758 10
The interaction between the colon tumor cell surface and the endothelial cell layer is an important component of tumor intravasation, extravasation, and metastasis. Multiple studies suggest that tumor cells may bind to
E-selectin
expressed on endothelial cells during these processes. To identify possible
E-selectin
ligands on tumor cells that may participate in this mechanism, we used
E-selectin
-Ig chimera affinity chromatography to isolate glycoproteins from the human colon cancer cell line Colo-205. Binding of these cells to
E-selectin
was specific, required the presence of calcium, and could be blocked by antibodies against
E-selectin
. We identified LAMP-1 (lysosomal membrane glycoprotein-1), LAMP-2, and two high molecular weight glycoproteins (>400 kDa and 300 kDa) as the main
E-selectin
ligands on Colo-205 cells. Treatment of the cells with
N-glycanase
and O-sialoglycoprotease abolished their binding to
E-selectin
. The high MW glycoproteins contained sialyl Lewis X and/or sialyl Lewis A glycoconjugates, and appeared to be either alternatively spliced or alternatively glycosylated forms of MUC-1 (mucin-1).
...
PMID:Human colon cancer cells express multiple glycoprotein ligands for E-selectin. 1063 80
Lectins have been widely used in glycan structure analysis. The studies described here exploit this fact to select glycopeptides carrying disease-associated modifications in their oligosaccharides. Coupling lectin affinity selection with recent advances in stable isotope coding for quantitative proteomics allowed a comparative proteomics method to be developed for examining aberrant glycosylation in cancer. Control and experimental samples were individually tryptic digested and differentially coded with stable isotope coding agents before they were mixed and affinity selected with a lectin affinity chromatography column. Glycopeptides carrying an alpha-L-fucose residue were selected with Lotus tetragonolobus agglutinin (LTA) immobilized on a chromatography matrix. Because the oligosaccharides of glycoproteins are generally heterogeneous and often of unknown structure, it was necessary to deglycosylate the selected peptides with
PNGase F
before they could be compared to sequences in DNA and protein databases. After deglycosylated peptides were transferred to a reversed phase chromatography (RPC) column and fractionated by gradient elution with increasing amounts of acetonitrile. The RPC fractions were then analyzed by both matrix-assisted laser desorption ionization mass spectrometry (MALDI-MS) and electrospray ionization mass spectrometry (ESI-MS). When this method was applied to a study of lymphosarcoma in canines, it was found that during chemotherapy, a series of fucosylated proteins in the blood of patients decreased in concentration more than 2-fold. Two of the proteins identified, CD44 and
E-selectin
, are known to be involved in cell adhesion and cancer cell migration. The observed aberrant fucosylation of these proteins is consistent with the hypothesis that CD44 and
E-selectin
play a key role in metastasis and the spread of cancer cells to remote sites.
...
PMID:Comparative proteomics of glycoproteins based on lectin selection and isotope coding. 1469 55